This is a Validated Antibody Database (VAD) review about human KRT8, based on 233 published articles (read how Labome selects the articles), using KRT8 antibody in all methods. It is aimed to help Labome visitors find the most suited KRT8 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KRT8 synonym: CARD2; CK-8; CK8; CYK8; K2C8; K8; KO

Knockout validation
Invitrogen
mouse monoclonal (TS1)
  • western blot knockout validation; mouse; fig 3
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT8 antibody (NeoMarkers, TS1) was used in western blot knockout validation on mouse samples (fig 3). Mol Cell Biol (2004) ncbi
Developmental Studies Hybridoma Bank
rat monoclonal (TROMA-I)
  • western blot knockout validation; mouse; fig 3
  • western blot knockout validation; human; fig 5
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, unknown) was used in western blot knockout validation on mouse samples (fig 3) and in western blot knockout validation on human samples (fig 5). Carcinogenesis (2016) ncbi
Developmental Studies Hybridoma Bank
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2
  • immunohistochemistry knockout validation; mouse; 1:50; fig 1
  • western blot; mouse; 1:500; fig s3
In order to research aggravation of murine caerulein-induced acute pancreatitis and the favoring of acinar keratin granule formation due to epiplakin deficiency, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, Troma I) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2), in immunohistochemistry knockout validation on mouse samples at 1:50 (fig 1) and in western blot on mouse samples at 1:500 (fig s3). PLoS ONE (2014) ncbi
Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6b
Invitrogen KRT8 antibody (eBioscience, 53-9003-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6b). Commun Biol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2, 4a, 4b
Invitrogen KRT8 antibody (InVitrogen, MA5-13156) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2, 4a, 4b). Mol Oncol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen KRT8 antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human; loading ...
Invitrogen KRT8 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen KRT8 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen KRT8 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen KRT8 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen KRT8 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen KRT8 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (5D3)
  • other; human; loading ...; fig s1
In order to investigate the mechanisms of toxicity by the negative allosteric modulators of metabotropic glutamate receptor 5, Invitrogen KRT8 antibody (Thermo Fisher, MA5-14088) was used in other on human samples (fig s1). Cell Chem Biol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen KRT8 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (AE3)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Invitrogen KRT8 antibody (eBioscience, 14-900-80) was used in flow cytometry on human samples . F1000Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen KRT8 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (TS1)
  • western blot; human; loading ...; fig 2e
In order to study factors that influence the localization of casein kinase 1, Invitrogen KRT8 antibody (Thermo Fisher, TS1) was used in western blot on human samples (fig 2e). Sci Rep (2016) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen KRT8 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen KRT8 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (TS1)
  • immunocytochemistry; human; fig 2c
  • western blot; human; fig 3h
In order to examine the effects of the FAM83H mutation on the keratin cytoskeleton and desmosomes in ameloblasts, Invitrogen KRT8 antibody (Thermo Scientific, TS1) was used in immunocytochemistry on human samples (fig 2c) and in western blot on human samples (fig 3h). Sci Rep (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen KRT8 antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (TS1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4
  • western blot; human; 1:1000; fig 4
In order to analyze high-grade serous epithelial ovarian cancer cell lines that show sporadic and hereditary disease and the molecular diversity, Invitrogen KRT8 antibody (Thermo Fisher Scientific, MS-997-P) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4) and in western blot on human samples at 1:1000 (fig 4). Genes Cancer (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen KRT8 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; human; fig 4
In order to describe an automated image method capable of discriminating epithelial and stromal areas of colorectal cancer samples, Invitrogen KRT8 antibody (Thermo Fisher Scientific, EP1628Y) was used in immunohistochemistry - paraffin section on human samples (fig 4). Biomed Res Int (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen KRT8 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen KRT8 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (5D3)
  • immunocytochemistry; human; 1:50; fig 5
In order to research chlamydia trachomatis and infection of human retinal pigment epithelium, Invitrogen KRT8 antibody (Thermo Scientific, MS-743-S) was used in immunocytochemistry on human samples at 1:50 (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT8 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
domestic rabbit polyclonal
In order to use chemical crosslinking and mass spectrometry to quantify changes in protein structures and interactions in multidrug-resistant human carcinoma cells, Invitrogen KRT8 antibody (Thermo Scientific, PA5-28985) was used . Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen KRT8 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; 1:100; fig s1
In order to develop an "antigen relaxing" method to improve routine detection of scarce antigens in formalin-fixed, paraffin-embedded material, Invitrogen KRT8 antibody (Thermo Scientific, 5D3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1). Appl Immunohistochem Mol Morphol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen KRT8 antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT8 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen KRT8 antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen KRT8 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen KRT8 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen KRT8 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry; human; 1:100
In order to describe a new method for immunohistochemistry optimization, Invitrogen KRT8 antibody (Neomarkers, MS 743-S) was used in immunohistochemistry on human samples at 1:100. Histopathology (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT8 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT8 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT8 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
domestic rabbit polyclonal
In order to characterize primary cultures of epithelial cells from adult human epididymis, Invitrogen KRT8 antibody (Thermo Fisher Scientific, PA532469) was used . Fertil Steril (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen KRT8 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen KRT8 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (TS1)
  • immunohistochemistry; human; 1:300
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen KRT8 antibody (Thermo Scientific, TS1) was used in immunohistochemistry on human samples at 1:300. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen KRT8 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen KRT8 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT8 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (8A5D12)
  • immunocytochemistry; human
In order to analyze the proteomes of 2D and 3D cell cultures, Invitrogen KRT8 antibody (Thermo Fisher Scientific, MA5-15460) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT8 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT8 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen KRT8 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen KRT8 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen KRT8 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen KRT8 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen KRT8 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT8 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen KRT8 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen KRT8 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
domestic rabbit monoclonal (SP102)
In order to examine the possible role of caspase-2 as a tumor suppressor in the mouse mammary carcinogenesis model, Invitrogen KRT8 antibody (Thermo Scientific, RM-2107-R7) was used . Cell Death Differ (2013) ncbi
domestic rabbit monoclonal (SP102)
  • flow cytometry; human; 1:200; fig s2
  • immunocytochemistry; human; 1:200; fig 6
In order to describe conditions that promote development of hPSC-derived simple epithelial cells, Invitrogen KRT8 antibody (Thermo Scientific, RM-2107-S0) was used in flow cytometry on human samples at 1:200 (fig s2) and in immunocytochemistry on human samples at 1:200 (fig 6). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT8 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen KRT8 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen KRT8 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen KRT8 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen KRT8 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to examine the suitability of PAXgene tissue fixation for (immuno)histological methods, Invitrogen KRT8 antibody (Neomarkers, MS 743-S) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2011) ncbi
mouse monoclonal (6B10)
  • immunohistochemistry; human; fig 2
In order to study the expression pattern of stem cells in the bulbar conjunctival epithelium, Invitrogen KRT8 antibody (Lab Vision, 6B10) was used in immunohistochemistry on human samples (fig 2). J Cell Physiol (2010) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT8 antibody (Zymed, AE3) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT8 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT8 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT8 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT8 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen KRT8 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (TS1)
  • western blot; human; 1:200; fig 6
In order to examine the biological responses imparted by Matrigel overlays on primary human hepatocyte cultures, Invitrogen KRT8 antibody (Neomarkers, MS-997) was used in western blot on human samples at 1:200 (fig 6). Toxicol Sci (2007) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen KRT8 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT8 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (TS1)
  • western blot knockout validation; mouse; fig 3
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT8 antibody (NeoMarkers, TS1) was used in western blot knockout validation on mouse samples (fig 3). Mol Cell Biol (2004) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT8 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen KRT8 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen KRT8 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1e
Abcam KRT8 antibody (Abcam, ab59400) was used in immunohistochemistry - paraffin section on mouse samples (fig s1e). Cell Death Dis (2022) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s7a
Abcam KRT8 antibody (Abcam, ab59400) was used in western blot on mouse samples at 1:1000 (fig s7a). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1g
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2d
Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1g) and in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2d). Cell Prolif (2021) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry; human; loading ...
Abcam KRT8 antibody (Abcam, 192467) was used in immunohistochemistry on human samples . elife (2021) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 5a
Abcam KRT8 antibody (Abcam, ab53280) was used in immunocytochemistry on mouse samples at 1:200 (fig 5a). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - frozen section; human; 1:20; loading ...; fig s1a
Abcam KRT8 antibody (Abcam, ab192467) was used in immunohistochemistry - frozen section on human samples at 1:20 (fig s1a). Cancer Res (2021) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 4f
Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry on mouse samples at 1:400 (fig 4f). elife (2020) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 8e
Abcam KRT8 antibody (abcam, ab53280) was used in immunohistochemistry - frozen section on mouse samples (fig 8e). Nat Commun (2020) ncbi
mouse monoclonal (C-43)
  • immunocytochemistry; human; 1:200; loading ...; fig s12
Abcam KRT8 antibody (Abcam, ab2530) was used in immunocytochemistry on human samples at 1:200 (fig s12). Sci Immunol (2020) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; fig 6a
Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a). Cancer Cell (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4a
Abcam KRT8 antibody (Abcam, ab59400) was used in immunohistochemistry - paraffin section on mouse samples (fig 4a). Biol Res (2019) ncbi
domestic rabbit monoclonal (EP1628Y)
  • western blot; human; loading ...; fig s4b
Abcam KRT8 antibody (Abcam, ab53280) was used in western blot on human samples (fig s4b). Cell (2019) ncbi
domestic rabbit monoclonal (E431-2)
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig 3
Abcam KRT8 antibody (Abcam, ab32579) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 3). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4b
Abcam KRT8 antibody (Abcam, ab192467) was used in immunohistochemistry on mouse samples at 1:100 (fig 4b). Cell Rep (2018) ncbi
mouse monoclonal (M20)
  • immunocytochemistry; human; 1:200; fig 4d
Abcam KRT8 antibody (Abcam, Ab9023) was used in immunocytochemistry on human samples at 1:200 (fig 4d). PLoS ONE (2018) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry; mouse; fig 2a
In order to investigate the interplay among ETS factors in prostate oncogenesis, Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry on mouse samples (fig 2a). Nature (2017) ncbi
mouse monoclonal (C-43)
  • immunocytochemistry; human; loading ...; fig 5d
Abcam KRT8 antibody (Abcam, ab2530) was used in immunocytochemistry on human samples (fig 5d). J Exp Med (2017) ncbi
mouse monoclonal (M20)
  • western blot; human; fig 2a
In order to identify pathways that contribute to resistance to the antiandrogen drug enzalutamide, Abcam KRT8 antibody (abcam, 9023) was used in western blot on human samples (fig 2a). Science (2017) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1b
In order to determine if PIK3CA mutations contribute to tumor initiation, Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples (fig 1b). Oncogenesis (2016) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 5a
Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5a). Am J Pathol (2016) ncbi
mouse monoclonal (M20)
  • western blot; human; 1:1000; fig 2
In order to analyze the contribution to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of formyl peptide receptor pathway by annexin A1, Abcam KRT8 antibody (Abcam, M20) was used in western blot on human samples at 1:1000 (fig 2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; human; 1:2000; loading ...; fig 5g
Abcam KRT8 antibody (Abcam, 53280) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 5g). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EP1628Y)
  • western blot; human; loading ...; fig s3
Abcam KRT8 antibody (Abcam, ab53280) was used in western blot on human samples (fig s3). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:500
In order to characterize the spontaneous peripheral squamous cell lung cancer in mice by ablation of liver X receptors alpha and beta, Abcam KRT8 antibody (Abcam, ab59400) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (E431-2)
  • western blot; human; fig s8a
In order to examine the effects of the FAM83H mutation on the keratin cytoskeleton and desmosomes in ameloblasts, Abcam KRT8 antibody (Abcam, E431-2) was used in western blot on human samples (fig s8a). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 6
In order to investigate breast tumorigenesis due to loss of Panx1 which impairs mammary gland development at lactation, Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 6). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; 1:800; fig 4
Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples at 1:800 (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 3
Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 2
Abcam KRT8 antibody (Abcam, EP16284) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 2). Prostate (2016) ncbi
mouse monoclonal (M20)
  • immunohistochemistry - paraffin section; human
In order to identify molecular alterations in the normal mucosa in the proximity of adenomatous polyps and assess the modulating effect of butyrate, Abcam KRT8 antibody (Abcam, ab9023) was used in immunohistochemistry - paraffin section on human samples . BMJ Open Gastroenterol (2015) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 5
In order to discuss Cx26 knockout in DMBA-induced mouse models and breast cancer, Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 5). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP1628Y)
  • immunohistochemistry - paraffin section; mouse; 1:500
Abcam KRT8 antibody (Abcam, ab53280) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Mol Cell Endocrinol (2015) ncbi
domestic rabbit monoclonal (E431-2)
  • immunohistochemistry; human; fig s3
  • western blot; human; 1:1000; fig  1
Abcam KRT8 antibody (Abcam, ab32579) was used in immunohistochemistry on human samples (fig s3) and in western blot on human samples at 1:1000 (fig  1). Cell Signal (2015) ncbi
mouse monoclonal (M20)
  • immunocytochemistry; human; 1:200
Abcam KRT8 antibody (Abcam, ab9023) was used in immunocytochemistry on human samples at 1:200. Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (C-43)
  • immunocytochemistry; human; 1:50; fig 4b
  • western blot; human; 1:1000; fig 4a
Abcam KRT8 antibody (Abcam, Ab2530) was used in immunocytochemistry on human samples at 1:50 (fig 4b) and in western blot on human samples at 1:1000 (fig 4a). Biochimie (2014) ncbi
mouse monoclonal (5D3)
  • immunohistochemistry; mouse; 1:50
  • flow cytometry; human; 1:200
Abcam KRT8 antibody (Abcam, ab17139) was used in immunohistochemistry on mouse samples at 1:50 and in flow cytometry on human samples at 1:200. Cell Transplant (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (0.N.352)
  • western blot; human; 1:1000; loading ...; fig 3a
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-70939) was used in western blot on human samples at 1:1000 (fig 3a). Sci Rep (2021) ncbi
mouse monoclonal (NCL-5D3)
  • immunohistochemistry; human; loading ...; fig 7e
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-52325) was used in immunohistochemistry on human samples (fig 7e). EMBO J (2021) ncbi
mouse monoclonal (M20)
  • western blot; mouse; 1:1000; loading ...; fig 2a
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, M20) was used in western blot on mouse samples at 1:1000 (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (M20)
  • immunohistochemistry - frozen section; human; loading ...; fig 6c
In order to identify and characterize extended pluripotent stem cells, Santa Cruz Biotechnology KRT8 antibody (SantaCruz, sc-52324) was used in immunohistochemistry - frozen section on human samples (fig 6c). Cell (2017) ncbi
mouse monoclonal (C11)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology KRT8 antibody (SantaCruz, sc-8018) was used in western blot on human samples (fig 3b). Eur J Pharmacol (2017) ncbi
mouse monoclonal (M20)
  • western blot; mouse; 1:500; loading ...; fig 3a
In order to evaluate the impacts of high fat diet on the insulin-adrenergic receptor signal network in hearts, Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, M-20) was used in western blot on mouse samples at 1:500 (fig 3a). J Physiol (2017) ncbi
mouse monoclonal (M20)
  • western blot; human; 1:1000; loading ...; fig 2
In order to elucidate the mechanisms by which Annexin A1 governs metastatic behavior in prostate cancer cells exposed to hypoxia, Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotechnologies, M20) was used in western blot on human samples at 1:1000 (fig 2). Cell Adh Migr (2017) ncbi
mouse monoclonal (M20)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-52324) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (C11)
  • immunohistochemistry - frozen section; human; fig 2
  • western blot; human; fig 1
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-8018) was used in immunohistochemistry - frozen section on human samples (fig 2) and in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (C11)
  • immunocytochemistry; rat; 1:10; fig 3
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-8018) was used in immunocytochemistry on rat samples at 1:10 (fig 3). Front Physiol (2016) ncbi
mouse monoclonal (C11)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1d
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-8018) was used in immunohistochemistry - paraffin section on mouse samples (fig 1d). Int J Biol Sci (2016) ncbi
mouse monoclonal (C11)
  • immunocytochemistry; rat; 1:50; fig 6
In order to develop a bioreactor to culture polarized respiratory epithelium, Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotechnology, sc-8018) was used in immunocytochemistry on rat samples at 1:50 (fig 6). Cell Med (2015) ncbi
mouse monoclonal
  • immunocytochemistry; human; loading ...; fig 1
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotechnology, C51) was used in immunocytochemistry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (C51)
  • immunocytochemistry; human; loading ...; fig 1
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotechnology, C51) was used in immunocytochemistry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (KS8.7)
  • immunohistochemistry - paraffin section; rat; 1:200; fig 2
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotechnology, sc-101459) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 2). J Ethnopharmacol (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; fig s1
Santa Cruz Biotechnology KRT8 antibody (Santa, sc-8018) was used in western blot on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (E-12)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-374274) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). J Biol Chem (2015) ncbi
mouse monoclonal (M20)
  • immunohistochemistry; rat; 1:100; loading ...; fig 6a
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, M-20) was used in immunohistochemistry on rat samples at 1:100 (fig 6a). Cardiovasc Pathol (2015) ncbi
mouse monoclonal (C50)
  • immunohistochemistry; mouse; 1:200; fig 8e
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotechnology, C50) was used in immunohistochemistry on mouse samples at 1:200 (fig 8e). Oncogene (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop and characterize a novel three-dimensional cell culture model of ovarian endometriosis, Santa Cruz Biotechnology KRT8 antibody (Santa, sc-8018) was used in western blot on human samples at 1:1000. J Ovarian Res (2014) ncbi
mouse monoclonal (KS8.7)
  • immunohistochemistry; rat; 1:20
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotechnology, sc-101459) was used in immunohistochemistry on rat samples at 1:20. Arthritis Res Ther (2014) ncbi
mouse monoclonal (KS8.7)
  • immunohistochemistry - paraffin section; rat; 1:20
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz Biotech., sc-101459) was used in immunohistochemistry - paraffin section on rat samples at 1:20. J Orthop Res (2014) ncbi
mouse monoclonal (5F295)
  • immunohistochemistry - paraffin section; mouse; fig 3
Santa Cruz Biotechnology KRT8 antibody (Santa Cruz, sc-70928) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). PLoS ONE (2013) ncbi
Miltenyi Biotec
mouse monoclonal (CK3-6H5)
  • flow cytometry; human
Miltenyi Biotec KRT8 antibody (Miltenyi Biotec, 130-118-964) was used in flow cytometry on human samples . Front Immunol (2022) ncbi
Abnova
mouse monoclonal (TS1)
  • western blot; human; 1:500
Abnova KRT8 antibody (Abnova, TS106) was used in western blot on human samples at 1:500. J Proteome Res (2014) ncbi
Fitzgerald Industries
  • immunohistochemistry; human; fig 1f
In order to study factors that allow tumor cells to metastasize, Fitzgerald Industries KRT8 antibody (Fitzgerald Industries, 20R-CP004) was used in immunohistochemistry on human samples (fig 1f). Mol Biol Cell (2017) ncbi
  • immunocytochemistry; mouse; 1:500; loading ...
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Fitzgerald Industries KRT8 antibody (Fitzgerald, 20R-CP004) was used in immunocytochemistry on mouse samples at 1:500. Nature (2017) ncbi
  • immunohistochemistry - paraffin section; mouse; fig 3
Fitzgerald Industries KRT8 antibody (Fitzgerald, 20R-CP004) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Oncogene (2016) ncbi
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 2
Fitzgerald Industries KRT8 antibody (Fitzgerald, 20R-CP004) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2). Oncotarget (2015) ncbi
  • immunohistochemistry - paraffin section; mouse; 1:200
  • western blot; mouse; 1:500
In order to elucidate the potential of PIK3CA to induce multipotency during tumorigenesis in the mammary gland, Fitzgerald Industries KRT8 antibody (Fitzgerald, 20R-CP004) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 and in western blot on mouse samples at 1:500. Nature (2015) ncbi
Cell Signaling Technology
mouse monoclonal (C51)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1b
  • western blot; human; 1:1000; loading ...; fig s1b
Cell Signaling Technology KRT8 antibody (Cell Signaling, 4546) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1b) and in western blot on human samples at 1:1000 (fig s1b). Cell Death Dis (2020) ncbi
mouse monoclonal (C51)
  • mass cytometry; human; loading ...; fig 3a
Cell Signaling Technology KRT8 antibody (Cell Signaling Technologies, 4546) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
mouse monoclonal (C51)
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology KRT8 antibody (Cell Signaling, 4546) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
Progen
mouse monoclonal (KS8.7)
  • immunohistochemistry - paraffin section; rat; loading ...; fig st6
In order to outline the protocols for antibodies used for immunohistochemical studies, Progen KRT8 antibody (Progen, 61038) was used in immunohistochemistry - paraffin section on rat samples (fig st6). J Toxicol Pathol (2017) ncbi
mouse monoclonal (KS8.7)
  • western blot; mouse; loading ...; fig s4b
In order to find a role for RelA in regulating oncogene-induced senescence, Progen KRT8 antibody (Progen Biotechnik, 61038) was used in western blot on mouse samples (fig s4b). J Clin Invest (2016) ncbi
Dako
domestic rabbit monoclonal (EP17/EP30)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4c
Dako KRT8 antibody (Dako, M3652) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4c). Oncotarget (2017) ncbi
Developmental Studies Hybridoma Bank
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:50; fig 5c
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples at 1:50 (fig 5c). Sci Transl Med (2022) ncbi
rat monoclonal (TROMA-I)
  • immunocytochemistry; mouse; 1:300; fig 3a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMAIc) was used in immunocytochemistry on mouse samples at 1:300 (fig 3a). Commun Biol (2022) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 1b
  • immunocytochemistry; mouse; 1:250; fig 1s2b
  • immunohistochemistry; mouse; 1:250; loading ...; fig 1a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 1b), in immunocytochemistry on mouse samples at 1:250 (fig 1s2b) and in immunohistochemistry on mouse samples at 1:250 (fig 1a). elife (2022) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:600; loading ...; fig 2c
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMAI) was used in immunohistochemistry - paraffin section on mouse samples at 1:600 (fig 2c). Mol Oncol (2022) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 7c
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 7c). elife (2021) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; loading ...; fig 4e
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMAI) was used in immunohistochemistry on mouse samples (fig 4e). Cell Rep (2021) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig s1e
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig s1e). Nat Commun (2021) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:1000; fig 5e
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunohistochemistry on mouse samples at 1:1000 (fig 5e). Dev Cell (2021) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 2a, 3i
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 2a, 3i). Sci Rep (2021) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; loading ...; fig s3b
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples (fig s3b). Cell Rep (2021) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5a
  • western blot; mouse; fig 4c
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, Troma I) was used in immunohistochemistry - paraffin section on mouse samples (fig 5a), in western blot on mouse samples (fig 4c) and in immunohistochemistry - paraffin section on human samples (fig 1a). Mucosal Immunol (2021) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; loading ...
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunohistochemistry on mouse samples . Cell Rep (2020) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; human; 1:200; fig 3c
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, Troma I) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 3c). Aging Cell (2020) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1a). Science (2020) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 4a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples at 1:1000 (fig 4a). elife (2020) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 1b
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank (DSHB), Troma-I) was used in immunohistochemistry on mouse samples at 1:500 (fig 1b). elife (2019) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 2a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA1) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 2a). Science (2019) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 5a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples at 1:100 (fig 5a). elife (2019) ncbi
rat monoclonal (TROMA-I)
  • immunocytochemistry; mouse; 1:10; loading ...; fig 1a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunocytochemistry on mouse samples at 1:10 (fig 1a). Nat Cell Biol (2019) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:20,000; loading ...; fig 2c
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, AB 531826) was used in immunohistochemistry - paraffin section on mouse samples at 1:20,000 (fig 2c). J Clin Invest (2019) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:30; loading ...; fig 4a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples at 1:30 (fig 4a). Breast Cancer Res (2018) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1i
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1s) was used in immunohistochemistry on mouse samples at 1:100 (fig 1i). Science (2018) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 2e
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2e). Genes Dev (2018) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; loading ...; fig 2j
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples (fig 2j). Sci Rep (2017) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2d
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, Troma-I) was used in immunohistochemistry - paraffin section on mouse samples (fig 2d). Development (2017) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s5a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples at 1:500 (fig s5a). Nat Cell Biol (2017) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; human; 1:20; loading ...; fig 6b
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - frozen section on human samples at 1:20 (fig 6b). Cell (2017) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:50; loading ...; fig s3
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples at 1:50 (fig s3). Cell (2017) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6c
In order to study the architecture of the mouse mammary gland using high-resolution 3D imaging, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c). Breast Cancer Res (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:500; loading ...
In order to report how hedgehog signaling and stromal composition impact prostate cancer, Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-1) was used in immunohistochemistry on mouse samples at 1:500. Dis Model Mech (2017) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; fig 6e
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples (fig 6e). J Exp Med (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 3b
In order to report the phenotypic and genetic changes within the pre-neoplastic mammary epithelium of mice with and without stromal PTEN expression, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 3b). Oncogene (2017) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 1b
In order to examine the differentiation potential of adult mammary stem cells, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 1b). Nat Commun (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 1
In order to study the contribution of sonic hedgehog signaling to Merkel cell formation, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 1). PLoS Genet (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig s4h
In order to develop tools to examine the fate and dynamics of stem cells during mammary gland and prostate development, Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, Troma-I) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s4h). Genes Dev (2016) ncbi
rat monoclonal (TROMA-I)
  • western blot knockout validation; mouse; fig 3
  • western blot knockout validation; human; fig 5
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, unknown) was used in western blot knockout validation on mouse samples (fig 3) and in western blot knockout validation on human samples (fig 5). Carcinogenesis (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; fig s1
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, Troma-I) was used in immunohistochemistry - paraffin section on mouse samples (fig s1). Oncotarget (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:100; fig 3
In order to analyze the interaction between BRCA1 and COBRA1 in mammary gland development and how genetic suppression reveals DNA repair-independent antagonism, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry on mouse samples at 1:100 (fig 3). Nat Commun (2016) ncbi
rat monoclonal (TROMA-I)
  • immunocytochemistry; mouse; fig 2
In order to follow the presence of K14+ compound niches present in mouse cornea early after birth through expansion after debridement wounds, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, Troma I) was used in immunocytochemistry on mouse samples (fig 2). Dev Dyn (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:100; fig 3
In order to analyze NFATc1 and its promotion of prostate tumorigenesis and its ability to overcome PTEN loss-induced senescence, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry on mouse samples at 1:100 (fig 3). Oncogene (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:50; fig 5
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry on mouse samples at 1:50 (fig 5). PLoS Genet (2015) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:250; fig s2
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig s2). Stem Cell Reports (2015) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - free floating section; mouse; 1:20; fig 2
In order to analyze the drive of Merkel cell production in postnatal, embryonic and adult mouse epidermis by ectopic Atoh1 expression, Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA1) was used in immunohistochemistry - free floating section on mouse samples at 1:20 (fig 2). Development (2015) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1a
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, Troma-I) was used in immunohistochemistry on mouse samples at 1:200 (fig 1a). Oncogene (2016) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; human
  • immunohistochemistry; mouse
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, Troma-1) was used in immunohistochemistry on human samples and in immunohistochemistry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:100
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMAI) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Nat Commun (2015) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; mouse; 1:20; fig 1
In order to characterize the Merkel cell population in embryonic and adult mice as unipotent, Atoh1+ progenitors, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry - frozen section on mouse samples at 1:20 (fig 1). J Cell Biol (2015) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:250; fig 4
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-1) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 4). J Cell Biol (2015) ncbi
rat monoclonal (TROMA-I)
  • immunocytochemistry; mouse; fig 3
Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-1) was used in immunocytochemistry on mouse samples (fig 3). Cytometry A (2015) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to determine the role of Tbx3 in different cell types present in the adult mammary gland, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. PLoS ONE (2014) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2
  • immunohistochemistry knockout validation; mouse; 1:50; fig 1
  • western blot; mouse; 1:500; fig s3
In order to research aggravation of murine caerulein-induced acute pancreatitis and the favoring of acinar keratin granule formation due to epiplakin deficiency, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, Troma I) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2), in immunohistochemistry knockout validation on mouse samples at 1:50 (fig 1) and in western blot on mouse samples at 1:500 (fig s3). PLoS ONE (2014) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; human
In order to evaluate a genomic strategy for the evaluation of transforming growth factor-beta in breast cancer, Developmental Studies Hybridoma Bank KRT8 antibody (Hybridoma Bank, Troma-1) was used in immunohistochemistry - paraffin section on human samples . Breast Cancer Res (2014) ncbi
rat monoclonal (TROMA-I)
  • western blot; human; fig 2
In order to identify molecules that block Hsp70 activity on keratin filaments during inflammation, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in western blot on human samples (fig 2). J Cell Sci (2014) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to study the role of TGFBR1 for mouse myometrial development, Developmental Studies Hybridoma Bank KRT8 antibody (DSHB, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Mol Endocrinol (2014) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - frozen section; mouse; 1:100
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, Troma-1) was used in immunohistochemistry - frozen section on mouse samples at 1:100. Dev Biol (2014) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse; 1:250
In order to study the role of cell migration in the mechanism by which overexpression of Cdc42 promotes developing mammary gland hyperbranching, Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunohistochemistry - paraffin section on mouse samples at 1:250. Breast Cancer Res (2013) ncbi
rat monoclonal (TROMA-I)
  • immunocytochemistry; mouse; 1:100
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-I) was used in immunocytochemistry on mouse samples at 1:100. Mol Endocrinol (2013) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry - paraffin section; mouse
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry - paraffin section on mouse samples . Biol Reprod (2013) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:200
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry on mouse samples at 1:200. Oncogene (2014) ncbi
rat monoclonal (TROMA-I)
  • immunohistochemistry; mouse; 1:100
Developmental Studies Hybridoma Bank KRT8 antibody (Developmental Studies Hybridoma Bank, TROMA-1) was used in immunohistochemistry on mouse samples at 1:100. J Comp Neurol (2010) ncbi
MilliporeSigma
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2h
MilliporeSigma KRT8 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2h). J Clin Invest (2021) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; rat; 1:200; loading ...; fig 2d
  • immunohistochemistry; human; 1:200; loading ...; fig 7f, s4
MilliporeSigma KRT8 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry on rat samples at 1:200 (fig 2d) and in immunohistochemistry on human samples at 1:200 (fig 7f, s4). Nat Commun (2021) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Cancer Immunol Immunother (2020) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry; human; loading ...; fig 7a
MilliporeSigma KRT8 antibody (Sigma, C2931) was used in immunohistochemistry on human samples (fig 7a). Cell Rep (2018) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2a
MilliporeSigma KRT8 antibody (Sigma, C-11) was used in immunohistochemistry - frozen section on mouse samples (fig 2a). PLoS ONE (2018) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:50; fig 3a
MilliporeSigma KRT8 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry on mouse samples at 1:50 (fig 3a). Science (2018) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - frozen section; mouse; 1:500; fig s4a
In order to discover that myoepithelial cells born early during submucosal gland morphogenesis are multipotent progenitors with the capacity to differentiate into other glandular cell types, MilliporeSigma KRT8 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s4a). Am J Respir Cell Mol Biol (2017) ncbi
mouse monoclonal (C-11)
  • immunocytochemistry; human; 1:100; loading ...; fig 6a
In order to discuss the relevance of vasculogenic mimicry in small cell lung cancer, MilliporeSigma KRT8 antibody (Sigma, C-11) was used in immunocytochemistry on human samples at 1:100 (fig 6a). Nat Commun (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study the role of Tsc2 in normal and pathological kidney and lung functions, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Am J Pathol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2a
In order to test if metastasis can be reduced by targeting cancer-associated fibroblasts with Pirfenidone, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig s5a
In order to study how tumor hypoxia affects DNA methylation, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples (fig s5a). Nature (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; pigs ; 1:100; loading ...; fig 5h
In order to build and characterize a novel bioreactor platform, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on pigs samples at 1:100 (fig 5h). Biotechnol J (2017) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:200
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:200. Nat Commun (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; loading ...; fig 2b
MilliporeSigma KRT8 antibody (Sigma, c2562) was used in immunohistochemistry on human samples (fig 2b). Nat Biotechnol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; human; 1:200; fig 5
MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunocytochemistry on human samples at 1:200 (fig 5). BMC Biol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; 1:4000; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry on human samples at 1:4000 (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (C-11)
  • western blot; human; 1:1000; fig 1
MilliporeSigma KRT8 antibody (Sigma, C-2931) was used in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; fig 2
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples (fig 2). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study a model of immune functions of the mouse blood-cerebrospinal fluid barrier in vitro using primary epithelial cells better suited to study immune cell migration across the brain barrier, MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). Fluids Barriers CNS (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). Clin Cancer Res (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse
MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:800; fig 5
MilliporeSigma KRT8 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:800 (fig 5). Dis Model Mech (2015) ncbi
mouse monoclonal (C-11)
  • western blot; rat
In order to characterize two new cell lines with the potential to be used to study portal (myo)fibroblasts, MilliporeSigma KRT8 antibody (Sigma-Aldrich, clone C-11) was used in western blot on rat samples . PLoS ONE (2015) ncbi
mouse monoclonal (C-11)
  • immunocytochemistry; domestic sheep; 10 ug/ml; loading ...
In order to study the reprogramming of ovine induced pluripotent stem cells, MilliporeSigma KRT8 antibody (Sigma, C2931) was used in immunocytochemistry on domestic sheep samples at 10 ug/ml. Cell Reprogram (2015) ncbi
mouse monoclonal (C-11)
  • immunocytochemistry; Xenopus laevis
MilliporeSigma KRT8 antibody (Sigma, C2931) was used in immunocytochemistry on Xenopus laevis samples . Zygote (2015) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to develop and validate a mouse model of endometriosis, MilliporeSigma KRT8 antibody (Sigma-Aldrich, #C2562) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Am J Pathol (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; rat
MilliporeSigma KRT8 antibody (Sigma, C2562) was used in western blot on rat samples . Carcinogenesis (2014) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:100
MilliporeSigma KRT8 antibody (Sigma-Aldrich, C-11) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:100. Biomaterials (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; pigs
  • western blot; human; 1:10,000
MilliporeSigma KRT8 antibody (Sigma-Aldrich, C 2562) was used in western blot on pigs samples and in western blot on human samples at 1:10,000. Mol Oncol (2014) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; Gallot's lizard; 1:400
In order to study the histogenesis of the lizard visual system, MilliporeSigma KRT8 antibody (Sigma-Aldrich, C2931) was used in immunohistochemistry - paraffin section on Gallot's lizard samples at 1:400. J Comp Neurol (2012) ncbi
Leica Biosystems
mouse monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 6a
Leica Biosystems KRT8 antibody (Novocastra, 5D3-L-CE) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 6a). Nat Commun (2018) ncbi
monoclonal (TS1)
  • immunocytochemistry; human; 1:25; loading ...; fig 2
In order to discuss estrogen receptor regulation and function in normal breast and breast cancer, Leica Biosystems KRT8 antibody (Novocastra, TS1) was used in immunocytochemistry on human samples at 1:25 (fig 2). Oncotarget (2017) ncbi
monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1A
  • immunocytochemistry; human; loading ...; fig S2B
Leica Biosystems KRT8 antibody (Leica, 5D3) was used in immunohistochemistry - paraffin section on human samples (fig 1A) and in immunocytochemistry on human samples (fig S2B). Oncotarget (2016) ncbi
monoclonal (5D3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 3
In order to characterize the spindle cell type of metaplastic breast carcinoma with myoepithelial features and report that this subtype exhibits a higher frequency of PIK3CA mutation than other types of metaplastic breast carcinoma, Leica Biosystems KRT8 antibody (Leica Biosystems, 5D3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). Virchows Arch (2016) ncbi
monoclonal (TS1)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to report the expression of senescence-associated lysosomal beta-galactosidase, p16, and p21 in different types of pituitary adenomas, Leica Biosystems KRT8 antibody (Leica Biosystems, TS1) was used in immunohistochemistry - paraffin section on human samples at 1:50. Endocr Pathol (2016) ncbi
Articles Reviewed
  1. Dinnon K, Leist S, Okuda K, Dang H, Fritch E, Gully K, et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci Transl Med. 2022;14:eabo5070 pubmed publisher
  2. Wu T, Wang W, Shi G, Hao M, Wang Y, Yao M, et al. Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death Dis. 2022;13:624 pubmed publisher
  3. Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher
  4. Kimura Yoshida C, Mochida K, Kanno S, Matsuo I. USP39 is essential for mammalian epithelial morphogenesis through upregulation of planar cell polarity components. Commun Biol. 2022;5:378 pubmed publisher
  5. Wang J, Liu C, He L, Xie Z, Bai L, Yu W, et al. Selective YAP activation in Procr cells is essential for ovarian stem/progenitor expansion and epithelium repair. elife. 2022;11: pubmed publisher
  6. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  7. Heitink L, Whittle J, Vaillant F, Capaldo B, Dekkers J, Dawson C, et al. In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis. Mol Oncol. 2022;16:1119-1131 pubmed publisher
  8. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed publisher
  9. Jung S, Kim D, Choi Y, Kim S, Park H, Lee H, et al. Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Sci Rep. 2021;11:19667 pubmed publisher
  10. Shao C, Lou P, Liu R, Bi X, Li G, Yang X, et al. Hormone-Responsive BMP Signaling Expands Myoepithelial Cell Lineages and Prevents Alveolar Precocity in Mammary Gland. Front Cell Dev Biol. 2021;9:691050 pubmed publisher
  11. Ide S, Kobayashi Y, Ide K, Strausser S, Abe K, Herbek S, et al. Ferroptotic stress promotes the accumulation of pro-inflammatory proximal tubular cells in maladaptive renal repair. elife. 2021;10: pubmed publisher
  12. Molina L, Zhu J, Li Q, Pradhan Sundd T, Krutsenko Y, Sayed K, et al. Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitors. Cell Rep. 2021;36:109310 pubmed publisher
  13. Brady N, Bagadion A, Singh R, Conteduca V, Van Emmenis L, Arceci E, et al. Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer. Nat Commun. 2021;12:3372 pubmed publisher
  14. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  15. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed publisher
  16. Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021;54:e13056 pubmed publisher
  17. Hendley A, Rao A, Leonhardt L, Ashe S, Smith J, Giacometti S, et al. Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. elife. 2021;10: pubmed publisher
  18. Benítez S, Cordero A, Santamaria P, Redondo Pedraza J, Rocha A, Collado Solé A, et al. RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness. Dev Cell. 2021;56:1727-1741.e7 pubmed publisher
  19. Repenning A, Happel D, Bouchard C, Meixner M, Verel Yilmaz Y, Raifer H, et al. PRMT1 promotes the tumor suppressor function of p14ARF and is indicative for pancreatic cancer prognosis. EMBO J. 2021;40:e106777 pubmed publisher
  20. Ni N, Fang X, Li Q. Functional similarity between TGF-beta type 2 and type 1 receptors in the female reproductive tract. Sci Rep. 2021;11:9294 pubmed publisher
  21. Gao H, Liu Y, Zheng M, Zhao F, Wang H, Yu J, et al. Characterization of murine mammary stem/progenitor cells in a D-galactose-induced aging model. Aging (Albany NY). 2021;13:11762-11773 pubmed publisher
  22. Carstens J, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews K, et al. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Rep. 2021;35:108990 pubmed publisher
  23. Krausová A, Buresova P, Sarnova L, Oyman Eyrilmez G, Skarda J, Wohl P, et al. Plectin ensures intestinal epithelial integrity and protects colon against colitis. Mucosal Immunol. 2021;14:691-702 pubmed publisher
  24. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  25. Singh S, Sutcliffe M, Repich K, Atkins K, Harvey J, Janes K. Pan-Cancer Drivers Are Recurrent Transcriptional Regulatory Heterogeneities in Early-Stage Luminal Breast Cancer. Cancer Res. 2021;81:1840-1852 pubmed publisher
  26. McGuire J, Frieling J, Lo C, Li T, Muhammad A, Lawrence H, et al. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nat Commun. 2021;12:723 pubmed publisher
  27. Wilson M, Reske J, Holladay J, Neupane S, Ngo J, Cuthrell N, et al. ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation. Cell Rep. 2020;33:108366 pubmed publisher
  28. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  29. Mevel R, Steiner I, Mason S, Galbraith L, Patel R, Fadlullah M, et al. RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development. elife. 2020;9: pubmed publisher
  30. Hall B, Gleiberman A, Strom E, Krasnov P, Frescas D, Vujcic S, et al. Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue. Aging Cell. 2020;19:e13219 pubmed publisher
  31. Neubarth N, Emanuel A, Liu Y, Springel M, Handler A, Zhang Q, et al. Meissner corpuscles and their spatially intermingled afferents underlie gentle touch perception. Science. 2020;368: pubmed publisher
  32. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  33. Pein M, Insua Rodríguez J, Hongu T, Riedel A, Meier J, Wiedmann L, et al. Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs. Nat Commun. 2020;11:1494 pubmed publisher
  34. Sun X, Are A, Annusver K, Sivan U, Jacob T, Dalessandri T, et al. Coordinated hedgehog signaling induces new hair follicles in adult skin. elife. 2020;9: pubmed publisher
  35. Costanzo Garvey D, Keeley T, Case A, Watson G, Alsamraae M, Yu Y, et al. Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunol Immunother. 2020;69:1113-1130 pubmed publisher
  36. Yamazaki Y, Urrutia R, Franco L, Giliani S, Zhang K, Alazami A, et al. PAX1 is essential for development and function of the human thymus. Sci Immunol. 2020;5: pubmed publisher
  37. Dragan M, Nguyen M, Guzman S, Goertzen C, Brackstone M, Dhillo W, et al. G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer. Cell Death Dis. 2020;11:106 pubmed publisher
  38. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  39. Fan D, Chettouh Z, Consalez G, Brunet J. Taste bud formation depends on taste nerves. elife. 2019;8: pubmed publisher
  40. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  41. Abdo H, Calvo Enrique L, Lopez J, Song J, Zhang M, Usoskin D, et al. Specialized cutaneous Schwann cells initiate pain sensation. Science. 2019;365:695-699 pubmed publisher
  42. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  43. Gao Y, Wei L, Wang C, Huang Y, Li W, Li T, et al. Chronic prostatitis alters the prostatic microenvironment and accelerates preneoplastic lesions in C57BL/6 mice. Biol Res. 2019;52:30 pubmed publisher
  44. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  45. Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L, et al. Reassessment of Exosome Composition. Cell. 2019;177:428-445.e18 pubmed publisher
  46. Saykali B, Mathiah N, Nahaboo W, Racu M, Hammou L, Defrance M, et al. Distinct mesoderm migration phenotypes in extra-embryonic and embryonic regions of the early mouse embryo. elife. 2019;8: pubmed publisher
  47. Jung H, Fattet L, Tsai J, Kajimoto T, Chang Q, Newton A, et al. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation. Nat Cell Biol. 2019;21:359-371 pubmed publisher
  48. Chen X, He Y, Xu A, Deng Z, Feng J, Lu F, et al. Increase of glandular epithelial cell clusters by an external volume expansion device promotes adipose tissue regeneration by recruiting macrophages. Biosci Rep. 2019;39: pubmed publisher
  49. Barros Silva J, Linn D, Steiner I, Guo G, Ali A, Pakula H, et al. Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Rep. 2018;25:3504-3518.e6 pubmed publisher
  50. Abeln M, Albers I, Peters Bernard U, Flächsig Schulz K, Kats E, Kispert A, et al. Sialic acid is a critical fetal defense against maternal complement attack. J Clin Invest. 2019;129:422-436 pubmed publisher
  51. Mao S, Park M, Cabrera R, Christin J, Karagiannis G, Oktay M, et al. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res. 2018;20:131 pubmed publisher
  52. Thyagarajan H, Lancaster J, Lira S, Ehrlich L. CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction. PLoS ONE. 2018;13:e0200765 pubmed publisher
  53. Chakrabarti R, Celià Terrassa T, Kumar S, Hang X, Wei Y, Choudhury A, et al. Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche. Science. 2018;360: pubmed publisher
  54. Pereira E, Kedrin D, Seano G, Gautier O, Meijer E, Jones D, et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science. 2018;359:1403-1407 pubmed publisher
  55. Poli V, Fagnocchi L, Fasciani A, Cherubini A, Mazzoleni S, Ferrillo S, et al. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Nat Commun. 2018;9:1024 pubmed publisher
  56. Takai K, Drain A, Lawson D, Littlepage L, Karpuj M, Kessenbrock K, et al. Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers. Genes Dev. 2018;32:244-257 pubmed publisher
  57. Hsieh W, Ramadesikan S, FEKETE D, Aguilar R. Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex. PLoS ONE. 2018;13:e0192635 pubmed publisher
  58. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  59. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed publisher
  60. Yeh Y, Gunasekharan V, Manuelidis L. A prokaryotic viral sequence is expressed and conserved in mammalian brain. Proc Natl Acad Sci U S A. 2017;114:7118-7123 pubmed publisher
  61. Bose R, Karthaus W, Armenia J, Abida W, Iaquinta P, Zhang Z, et al. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis. Nature. 2017;546:671-675 pubmed publisher
  62. Watanabe Y, Miyasaka K, Kubo A, Kida Y, Nakagawa O, Hirate Y, et al. Notch and Hippo signaling converge on Strawberry Notch 1 (Sbno1) to synergistically activate Cdx2 during specification of the trophectoderm. Sci Rep. 2017;7:46135 pubmed publisher
  63. Yang Y, Liu B, Xu J, Wang J, Wu J, Shi C, et al. Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency. Cell. 2017;169:243-257.e25 pubmed publisher
  64. Mekhdjian A, Kai F, Rubashkin M, Prahl L, Przybyla L, McGregor A, et al. Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix. Mol Biol Cell. 2017;28:1467-1488 pubmed publisher
  65. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  66. Hennenberg M, Tamalunas A, Wang Y, Keller P, Schott M, Strittmatter F, et al. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region. Eur J Pharmacol. 2017;803:39-47 pubmed publisher
  67. Saarela U, Akram S, Desgrange A, Rak Raszewska A, Shan J, Cereghini S, et al. Novel fixed z-direction (FiZD) kidney primordia and an organoid culture system for time-lapse confocal imaging. Development. 2017;144:1113-1117 pubmed publisher
  68. Fu N, Rios A, Pal B, Law C, Jamieson P, Liu R, et al. Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive. Nat Cell Biol. 2017;19:164-176 pubmed publisher
  69. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  70. Volpi S, Yamazaki Y, Brauer P, van Rooijen E, Hayashida A, Slavotinek A, et al. EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay. J Exp Med. 2017;214:623-637 pubmed publisher
  71. Wu J, Platero Luengo A, Sakurai M, Sugawara A, Gil M, Yamauchi T, et al. Interspecies Chimerism with Mammalian Pluripotent Stem Cells. Cell. 2017;168:473-486.e15 pubmed publisher
  72. Anderson P, Lynch T, Engelhardt J. Multipotent Myoepithelial Progenitor Cells Are Born Early during Airway Submucosal Gland Development. Am J Respir Cell Mol Biol. 2017;56:716-726 pubmed publisher
  73. Abboud Jarrous G, Priya S, Maimon A, Fischman S, Cohen Elisha M, Czerninski R, et al. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL. Oncotarget. 2017;8:13986-14002 pubmed publisher
  74. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  75. Hopkinson B, Klitgaard M, Petersen O, Villadsen R, Rønnov Jessen L, Kim J. Establishment of a normal-derived estrogen receptor-positive cell line comparable to the prevailing human breast cancer subtype. Oncotarget. 2017;8:10580-10593 pubmed publisher
  76. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  77. Mu P, Zhang Z, Benelli M, Karthaus W, Hoover E, Chen C, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84-88 pubmed publisher
  78. Abraira V, Kuehn E, Chirila A, Springel M, Toliver A, Zimmerman A, et al. The Cellular and Synaptic Architecture of the Mechanosensory Dorsal Horn. Cell. 2017;168:295-310.e19 pubmed publisher
  79. Fu Q, Hu Y, Wang Q, Liu Y, Li N, Xu B, et al. High-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of β2 -adrenergic receptor and impairs cardiac adrenergic reserve in animal hearts. J Physiol. 2017;595:1973-1986 pubmed publisher
  80. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  81. Lloyd Lewis B, Davis F, Harris O, Hitchcock J, Lourenco F, Pasche M, et al. Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods. Breast Cancer Res. 2016;18:127 pubmed
  82. Yang Z, Peng Y, Gopalan A, Gao D, Chen Y, Joyner A. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer. Dis Model Mech. 2017;10:39-52 pubmed publisher
  83. Kugler D, Flomerfelt F, Costa D, Laky K, Kamenyeva O, Mittelstadt P, et al. Systemic toxoplasma infection triggers a long-term defect in the generation and function of naive T lymphocytes. J Exp Med. 2016;213:3041-3056 pubmed
  84. Bizzarro V, Belvedere R, Migliaro V, Romano E, Parente L, Petrella A. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness. Cell Adh Migr. 2017;11:247-260 pubmed publisher
  85. Williamson S, Metcalf R, Trapani F, Mohan S, Antonello J, Abbott B, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322 pubmed publisher
  86. Sizemore G, Balakrishnan S, Hammer A, Thies K, Trimboli A, Wallace J, et al. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1. Oncogene. 2017;36:2297-2308 pubmed publisher
  87. Sheen M, Marotti J, Allegrezza M, Rutkowski M, Conejo Garcia J, Fiering S. Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer. Oncogenesis. 2016;5:e267 pubmed publisher
  88. Davis F, Lloyd Lewis B, Harris O, Kozar S, Winton D, Muresan L, et al. Single-cell lineage tracing in the mammary gland reveals stochastic clonal dispersion of stem/progenitor cell progeny. Nat Commun. 2016;7:13053 pubmed publisher
  89. Ren S, Luo Y, Chen H, Warburton D, Lam H, Wang L, et al. Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization. Am J Pathol. 2016;186:3261-3272 pubmed publisher
  90. Takai K, Le A, Weaver V, Werb Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 2016;7:82889-82901 pubmed publisher
  91. Kuga T, Kume H, Adachi J, Kawasaki N, Shimizu M, Hoshino I, et al. Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON. Sci Rep. 2016;6:34472 pubmed publisher
  92. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  93. Hubbs A, Fluharty K, Edwards R, Barnabei J, Grantham J, Palmer S, et al. Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity. Am J Pathol. 2016;186:2887-2908 pubmed publisher
  94. Thienpont B, Steinbacher J, Zhao H, D Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537:63-68 pubmed publisher
  95. Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed publisher
  96. Schuerlein S, Schwarz T, Krziminski S, Gätzner S, Hoppensack A, Schwedhelm I, et al. A versatile modular bioreactor platform for Tissue Engineering. Biotechnol J. 2017;12: pubmed publisher
  97. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  98. Lesina M, Wörmann S, Morton J, Diakopoulos K, Korneeva O, Wimmer M, et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest. 2016;126:2919-32 pubmed publisher
  99. Perdigoto C, Dauber K, Bar C, Tsai P, Valdes V, Cohen I, et al. Polycomb-Mediated Repression and Sonic Hedgehog Signaling Interact to Regulate Merkel Cell Specification during Skin Development. PLoS Genet. 2016;12:e1006151 pubmed publisher
  100. Belvedere R, Bizzarro V, Forte G, Dal Piaz F, Parente L, Petrella A. Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Sci Rep. 2016;6:29660 pubmed publisher
  101. Chen H, Wei Z, Sun J, Bhattacharya A, Savage D, Serda R, et al. A recellularized human colon model identifies cancer driver genes. Nat Biotechnol. 2016;34:845-51 pubmed publisher
  102. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  103. Stock K, Estrada M, Vidic S, Gjerde K, Rudisch A, Santo V, et al. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep. 2016;6:28951 pubmed publisher
  104. Madureira P, Bharadwaj A, Bydoun M, Garant K, O Connell P, Lee P, et al. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget. 2016;7:47720-47737 pubmed publisher
  105. Dai Y, Miao Y, Wu W, Li Y, D Errico F, Su W, et al. Ablation of Liver X receptors ? and ? leads to spontaneous peripheral squamous cell lung cancer in mice. Proc Natl Acad Sci U S A. 2016;113:7614-9 pubmed publisher
  106. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  107. Wuidart A, Ousset M, Rulands S, Simons B, Van Keymeulen A, Blanpain C. Quantitative lineage tracing strategies to resolve multipotency in tissue-specific stem cells. Genes Dev. 2016;30:1261-77 pubmed publisher
  108. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  109. Misiorek J, Lähdeniemi I, Nyström J, Paramonov V, Gullmets J, Saarento H, et al. Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway. Carcinogenesis. 2016;37:777-786 pubmed publisher
  110. Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D, et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009 pubmed publisher
  111. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed publisher
  112. Leo F, Bartels S, Mägel L, Framke T, Büsche G, Jonigk D, et al. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer. Virchows Arch. 2016;469:191-201 pubmed publisher
  113. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  114. Giovannini C, Minguzzi M, Genovese F, Baglioni M, Gualandi A, Ravaioli M, et al. Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma. Oncotarget. 2016;7:39609-39626 pubmed publisher
  115. Alaee M, Danesh G, Pasdar M. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS ONE. 2016;11:e0154323 pubmed publisher
  116. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  117. Stewart M, Plante I, Penuela S, Laird D. Loss of Panx1 Impairs Mammary Gland Development at Lactation: Implications for Breast Tumorigenesis. PLoS ONE. 2016;11:e0154162 pubmed publisher
  118. Wang Y, Gratzke C, Tamalunas A, Wiemer N, Ciotkowska A, Rutz B, et al. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate. PLoS ONE. 2016;11:e0153312 pubmed publisher
  119. El Mourabit H, Loeuillard E, Lemoinne S, Cadoret A, Housset C. Culture Model of Rat Portal Myofibroblasts. Front Physiol. 2016;7:120 pubmed publisher
  120. Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y, et al. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci. 2016;12:381-8 pubmed publisher
  121. Mancini M, Lien E, Toker A. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis. Oncotarget. 2016;7:17301-13 pubmed publisher
  122. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  123. Nair S, Zhang X, Chiang H, Jahid M, Wang Y, Garza P, et al. Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development. Nat Commun. 2016;7:10913 pubmed publisher
  124. Du L, Chen X, Cao Y, Lu L, Zhang F, Bornstein S, et al. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling. Oncogene. 2016;35:4641-52 pubmed publisher
  125. Raredon M, Ghaedi M, Calle E, Niklason L. A Rotating Bioreactor for Scalable Culture and Differentiation of Respiratory Epithelium. Cell Med. 2015;7:109-21 pubmed publisher
  126. Lazarevic I, Engelhardt B. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier. Fluids Barriers CNS. 2016;13:2 pubmed publisher
  127. Ruiz A, Rockfield S, Taran N, Haller E, Engelman R, Flores I, et al. Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis. Cell Death Dis. 2016;7:e2059 pubmed publisher
  128. Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein N, et al. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer. PLoS ONE. 2015;10:e0144535 pubmed publisher
  129. Zhang H, Zheng T, Chua C, Shen M, Gelmann E. Nkx3.1 controls the DNA repair response in the mouse prostate. Prostate. 2016;76:402-8 pubmed publisher
  130. Fleury H, Communal L, Carmona E, Portelance L, Arcand S, Rahimi K, et al. Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes Cancer. 2015;6:378-398 pubmed
  131. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  132. Rogojanu R, Thalhammer T, Thiem U, Heindl A, Mesteri I, Seewald A, et al. Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic Tool. Biomed Res Int. 2015;2015:569071 pubmed publisher
  133. Manojlović Gacić E, Skender Gazibara M, Popovic V, Soldatovic I, Boricic N, Raičević S, et al. Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study. Endocr Pathol. 2016;27:1-11 pubmed publisher
  134. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  135. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  136. Boiko E, Maltsev D, Savicheva A, Shalepo K, Khusnutdinova T, Pozniak A, et al. Infection of Human Retinal Pigment Epithelium with Chlamydia trachomatis. PLoS ONE. 2015;10:e0141754 pubmed publisher
  137. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  138. Pajoohesh Ganji A, Pal Ghosh S, Tadvalkar G, Stepp M. K14 + compound niches are present on the mouse cornea early after birth and expand after debridement wounds. Dev Dyn. 2016;245:132-43 pubmed publisher
  139. Manda K, Tripathi P, Hsi A, Ning J, Ruzinova M, Liapis H, et al. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence. Oncogene. 2016;35:3282-92 pubmed publisher
  140. Evans C, Rosser R, Waby J, Noirel J, Lai D, Wright P, et al. Reduced keratin expression in colorectal neoplasia and associated fields is reversible by diet and resection. BMJ Open Gastroenterol. 2015;2:e000022 pubmed publisher
  141. Hurley P, Sundi D, Shinder B, Simons B, Hughes R, Miller R, et al. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res. 2016;22:448-58 pubmed publisher
  142. Stewart M, Bechberger J, Welch I, Naus C, Laird D. Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer. Oncotarget. 2015;6:37185-99 pubmed publisher
  143. Davila J, Laws M, Kannan A, Li Q, Taylor R, Bagchi M, et al. Rac1 Regulates Endometrial Secretory Function to Control Placental Development. PLoS Genet. 2015;11:e1005458 pubmed publisher
  144. Chang C, Zhang M, Rajapakshe K, Coarfa C, Edwards D, Huang S, et al. Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage. Stem Cell Reports. 2015;5:378-91 pubmed publisher
  145. Pickup M, Hover L, Guo Y, Gorska A, Chytil A, Novitskiy S, et al. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget. 2015;6:22890-904 pubmed
  146. Koren S, Reavie L, Couto J, De Silva D, Stadler M, Roloff T, et al. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. 2015;525:114-8 pubmed publisher
  147. Chavez J, Schweppe D, Eng J, Zheng C, Taipale A, Zhang Y, et al. Quantitative interactome analysis reveals a chemoresistant edgotype. Nat Commun. 2015;6:7928 pubmed publisher
  148. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  149. Ostrowski S, Wright M, Bolock A, Geng X, Maricich S. Ectopic Atoh1 expression drives Merkel cell production in embryonic, postnatal and adult mouse epidermis. Development. 2015;142:2533-44 pubmed publisher
  150. Hein S, Haricharan S, Johnston A, Toneff M, Reddy J, Dong J, et al. Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress. Oncogene. 2016;35:1461-7 pubmed publisher
  151. Yuri S, Nishikawa M, Yanagawa N, Jo O, Yanagawa N. Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor. PLoS ONE. 2015;10:e0129242 pubmed publisher
  152. Scalia C, Gendusa R, Cattoretti G. A 2-Step Laemmli and Antigen Retrieval Method Improves Immunodetection. Appl Immunohistochem Mol Morphol. 2016;24:436-46 pubmed publisher
  153. Berry R, Ozdemir D, Aronow B, Lindström N, Dudnakova T, Thornburn A, et al. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice. Dis Model Mech. 2015;8:903-17 pubmed publisher
  154. Abbasi A, Khalaj M, Akiyama K, Mukai Y, Matsumoto H, Acosta T, et al. Lack of Rev7 function results in development of tubulostromal adenomas in mouse ovary. Mol Cell Endocrinol. 2015;412:19-25 pubmed publisher
  155. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  156. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  157. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  158. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  159. Yongping M, Zhang X, Xuewei L, Fan W, Chen J, Zhang H, et al. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation. J Ethnopharmacol. 2015;169:200-9 pubmed publisher
  160. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  161. Fausther M, Goree J, Lavoie Ã, Graham A, Sévigny J, Dranoff J. Establishment and characterization of rat portal myofibroblast cell lines. PLoS ONE. 2015;10:e0121161 pubmed publisher
  162. Kawada M, Inoue H, Ohba S, Yoshida J, Masuda T, Yamasaki M, et al. Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction. PLoS ONE. 2015;10:e0119415 pubmed publisher
  163. Tanaka T, Iino M. Sec8 regulates cytokeratin8 phosphorylation and cell migration by controlling the ERK and p38 MAPK signalling pathways. Cell Signal. 2015;27:1110-9 pubmed publisher
  164. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  165. Kap M, Lam K, Ewing Graham P, Riegman P. A reference image-based method for optimization of clinical immunohistochemistry. Histopathology. 2015;67:193-205 pubmed publisher
  166. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  167. Chandler R, Damrauer J, Raab J, Schisler J, Wilkerson M, Didion J, et al. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun. 2015;6:6118 pubmed publisher
  168. Wright M, Reed Geaghan E, Bolock A, Fujiyama T, Hoshino M, Maricich S. Unipotent, Atoh1+ progenitors maintain the Merkel cell population in embryonic and adult mice. J Cell Biol. 2015;208:367-79 pubmed publisher
  169. Roarty K, Shore A, Creighton C, Rosen J. Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium. J Cell Biol. 2015;208:351-66 pubmed publisher
  170. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  171. Petrosyan A, Ali M, Cheng P. Keratin 1 plays a critical role in golgi localization of core 2 N-acetylglucosaminyltransferase M via interaction with its cytoplasmic tail. J Biol Chem. 2015;290:6256-69 pubmed publisher
  172. Richardson G, Lannigan J, Macara I. Does FACS perturb gene expression?. Cytometry A. 2015;87:166-75 pubmed publisher
  173. Leir S, Browne J, Eggener S, Harris A. Characterization of primary cultures of adult human epididymis epithelial cells. Fertil Steril. 2015;103:647-54.e1 pubmed publisher
  174. German S, Campbell K, Thornton E, McLachlan G, Sweetman D, Alberio R. Ovine induced pluripotent stem cells are resistant to reprogramming after nuclear transfer. Cell Reprogram. 2015;17:19-27 pubmed publisher
  175. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  176. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  177. Mata K, Tefé Silva C, Floriano E, Fernandes C, Rizzi E, Gerlach R, et al. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms. Cardiovasc Pathol. 2015;24:110-20 pubmed publisher
  178. Kunasegaran K, Ho V, Chang T, De Silva D, Bakker M, Christoffels V, et al. Transcriptional repressor Tbx3 is required for the hormone-sensing cell lineage in mammary epithelium. PLoS ONE. 2014;9:e110191 pubmed publisher
  179. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  180. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  181. Wögenstein K, Szabo S, Lunova M, Wiche G, Haybaeck J, Strnad P, et al. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. PLoS ONE. 2014;9:e108323 pubmed publisher
  182. Chierchia L, Tussellino M, Guarino D, Carotenuto R, DeMarco N, Campanella C, et al. Cytoskeletal proteins associate with components of the ribosomal maturation and translation apparatus in Xenopus stage I oocytes. Zygote. 2015;23:669-82 pubmed publisher
  183. Wrzesinski K, Rogowska Wrzesinska A, Kanlaya R, Borkowski K, Schwämmle V, Dai J, et al. The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments. PLoS ONE. 2014;9:e106973 pubmed publisher
  184. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  185. Genovese F, Gualandi A, Taddia L, Marverti G, Pirondi S, Marraccini C, et al. Mass spectrometric/bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptides. J Proteome Res. 2014;13:5250-61 pubmed publisher
  186. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  187. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  188. Yun E, Baek S, Xie D, Tseng S, Dobin T, Hernandez E, et al. DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1. Oncogene. 2015;34:2741-52 pubmed publisher
  189. Greaves E, Cousins F, Murray A, Esnal Zufiaurre A, Fassbender A, Horne A, et al. A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium. Am J Pathol. 2014;184:1930-9 pubmed publisher
  190. Sato M, Kadota M, Tang B, Yang H, Yang Y, Shan M, et al. An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-? in human breast cancer. Breast Cancer Res. 2014;16:R57 pubmed publisher
  191. Mashukova A, Kozhekbaeva Z, Forteza R, Dulam V, Figueroa Y, Warren R, et al. The BAG-1 isoform BAG-1M regulates keratin-associated Hsp70 chaperoning of aPKC in intestinal cells during activation of inflammatory signaling. J Cell Sci. 2014;127:3568-77 pubmed publisher
  192. Gao Y, Bayless K, Li Q. TGFBR1 is required for mouse myometrial development. Mol Endocrinol. 2014;28:380-94 pubmed publisher
  193. Ryszawy D, Sarna M, Rak M, Szpak K, Kedracka Krok S, Michalik M, et al. Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer. Carcinogenesis. 2014;35:1920-30 pubmed publisher
  194. Brueggmann D, Templeman C, Starzinski Powitz A, Rao N, Gayther S, Lawrenson K. Novel three-dimensional in vitro models of ovarian endometriosis. J Ovarian Res. 2014;7:17 pubmed publisher
  195. Yurube T, Hirata H, Kakutani K, Maeno K, Takada T, Zhang Z, et al. Notochordal cell disappearance and modes of apoptotic cell death in a rat tail static compression-induced disc degeneration model. Arthritis Res Ther. 2014;16:R31 pubmed publisher
  196. Liu Z, Yu N, Holz F, Yang F, Stanzel B. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials. 2014;35:2837-50 pubmed publisher
  197. Wang S, Huang S, Zhao X, Zhang Q, Wu M, Sun F, et al. Enrichment of prostate cancer stem cells from primary prostate cancer cultures of biopsy samples. Int J Clin Exp Pathol. 2014;7:184-93 pubmed
  198. Stratmann A, Fecher D, Wangorsch G, Göttlich C, Walles T, Walles H, et al. Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model. Mol Oncol. 2014;8:351-65 pubmed publisher
  199. Huang T, Krimm R. BDNF and NT4 play interchangeable roles in gustatory development. Dev Biol. 2014;386:308-20 pubmed publisher
  200. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  201. Hirata H, Yurube T, Kakutani K, Maeno K, Takada T, Yamamoto J, et al. A rat tail temporary static compression model reproduces different stages of intervertebral disc degeneration with decreased notochordal cell phenotype. J Orthop Res. 2014;32:455-63 pubmed publisher
  202. Elakoum R, Gauchotte G, Oussalah A, Wissler M, Clément Duchêne C, Vignaud J, et al. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features. Biochimie. 2014;97:210-8 pubmed publisher
  203. Xu D, Nishimura T, Zheng M, Wu M, Su H, Sato N, et al. Enabling autologous human liver regeneration with differentiated adipocyte stem cells. Cell Transplant. 2014;23:1573-84 pubmed publisher
  204. Bray K, Gillette M, Young J, Loughran E, Hwang M, Sears J, et al. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration. Breast Cancer Res. 2013;15:R91 pubmed
  205. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  206. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  207. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  208. Stewart C, Wang Y, Bonilla Claudio M, Martin J, Gonzalez G, Taketo M, et al. CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development. Mol Endocrinol. 2013;27:1442-54 pubmed publisher
  209. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  210. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  211. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  212. Okumura N, Akutsu H, Sugawara T, Miura T, Takezawa Y, Hosoda A, et al. ?-catenin functions pleiotropically in differentiation and tumorigenesis in mouse embryo-derived stem cells. PLoS ONE. 2013;8:e63265 pubmed publisher
  213. Sizemore G, Sizemore S, Pal B, Booth C, Seachrist D, Abdul Karim F, et al. FOXC1 is enriched in the mammary luminal progenitor population, but is not necessary for mouse mammary ductal morphogenesis. Biol Reprod. 2013;89:10 pubmed publisher
  214. Parsons M, McCormick L, Janke L, Howard A, Bouchier Hayes L, Green D. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice. Cell Death Differ. 2013;20:1174-82 pubmed publisher
  215. Tripathi P, Wang Y, Coussens M, Manda K, Casey A, Lin C, et al. Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. Oncogene. 2014;33:1840-9 pubmed publisher
  216. Lian X, Selekman J, Bao X, Hsiao C, Zhu K, Palecek S. A small molecule inhibitor of SRC family kinases promotes simple epithelial differentiation of human pluripotent stem cells. PLoS ONE. 2013;8:e60016 pubmed publisher
  217. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  218. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  219. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  220. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  221. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  222. Romero Alemán M, Monzon Mayor M, Santos E, Lang D, Yanes C. Neuronal and glial differentiation during lizard (Gallotia galloti) visual system ontogeny. J Comp Neurol. 2012;520:2163-84 pubmed publisher
  223. Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, et al. Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS ONE. 2011;6:e27704 pubmed publisher
  224. Patel A, Huang T, Krimm R. Lingual and palatal gustatory afferents each depend on both BDNF and NT-4, but the dependence is greater for lingual than palatal afferents. J Comp Neurol. 2010;518:3290-301 pubmed publisher
  225. Qi H, Zheng X, Yuan X, Pflugfelder S, Li D. Potential localization of putative stem/progenitor cells in human bulbar conjunctival epithelium. J Cell Physiol. 2010;225:180-5 pubmed publisher
  226. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  227. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  228. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  229. Page J, Johnson M, Olsavsky K, Strom S, Zarbl H, Omiecinski C. Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture. Toxicol Sci. 2007;97:384-97 pubmed
  230. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  231. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  232. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  233. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed